Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Designing phase II studies of chemotherapy for HIV infection using CD4 as an end-point.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Designing phase II studies of chemotherapy for HIV infection using CD4 as an end-point.
Schoenfeld DA, Finkelstein DM, Richman DD. Designing phase II studies of chemotherapy for HIV infection using CD4 as an end-point. AIDS. 1993 Jul; 7(7):955-8.
View in:
PubMed
subject areas
Acquired Immunodeficiency Syndrome
AIDS-Related Complex
CD4-Positive T-Lymphocytes
Clinical Trials, Phase II as Topic
Drug Therapy, Combination
HIV Infections
Humans
Research Design
Time Factors
T-Lymphocyte Subsets
Zidovudine
authors with profiles
David Alan Schoenfeld, Ph.D.
Dianne Madelyn Finkelstein, Ph.D.